Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TBE (Tick-borne Encephalitis ) Vaccination in Allergic Patients

NCT02511535 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02511535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02511535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TBE (Tick-borne Encephalitis ) Vaccination in Allergic Patients
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2013
Completion date
September 30, 2016
Enrollment
119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine responsiveness during allergy de-sensitization treatment, vaccine responsiveness in allergy